Zenodo
What are the best BTK inhibitors for adult patients with malignancies?
By Tripdatabase.
Abstract
Ibrutinib, acalabrutinib, zanubrutinib, and pirtobrutinib are all effective BTK inhibitors for treating certain B-cell malignancies, each with different profiles of benefits and side effects. The choice of agent should consider individual patient needs, safety concerns, and specific clinical scenarios.
Keywords
- Chronic Lymphocytic Leukemia Research
- BTK inhibitors
- ibrutinib
- acalabrutinib
- zanubrutinib
- pirtobrutinib
- B-cell malignancies